Swiss Auto Components Stock News

SWX:HUBN
SWX:HUBNElectrical

European Stocks That May Be Priced Below Their Estimated Value

As European markets face heightened uncertainty due to geopolitical tensions and rising energy costs, the STOXX Europe 600 Index has seen a decline of 3.79%, reflecting investor caution. In this environment, identifying stocks that are potentially undervalued can be an effective strategy for investors looking to capitalize on discrepancies between current market prices and intrinsic value estimates.
SWX:HOLN
SWX:HOLNBasic Materials

European Growth Stocks With Strong Insider Ownership March 2026

As European markets navigate heightened uncertainty stemming from geopolitical tensions and rising energy costs, investors are increasingly focusing on companies with strong fundamentals and insider confidence. In this environment, growth stocks with substantial insider ownership can offer a unique perspective on potential resilience and alignment of interests between management and shareholders.
SWX:LOGN
SWX:LOGNTech

Logitech International’s Valuation After New US$1.4b Buyback Plan And Logitech G RS H Shifter Launch

Logitech International (SWX:LOGN) has drawn fresh attention after announcing a share repurchase plan of up to US$1.4b, alongside the global launch of its Logitech G RS H-Shifter for sim racing enthusiasts. See our latest analysis for Logitech International. The share repurchase news comes after a mixed stretch for the stock. A 2.11% 1-day share price return contrasts with a 7-day decline of 4.33%. Meanwhile, the 3-year total shareholder return of 55.50% stands out against a weaker 1-year...
SWX:TECN
SWX:TECNLife Sciences

Assessing Tecan Group (SWX:TECN) Valuation After New NVIDIA AI Collaboration News

AI-focused partnership shifts attention toward Tecan Group stock Tecan Group (SWX:TECN) has drawn renewed attention after announcing a collaboration with NVIDIA to integrate GPU-accelerated AI models into its laboratory instruments, with the aim of supporting data driven labs and higher research productivity. See our latest analysis for Tecan Group. The AI partnership headlines arrive after a volatile stretch for the stock, with a 1-day share price return of 9.07% and a 30-day share price...
SWX:ABBN
SWX:ABBNElectrical

Assessing ABB (SWX:ABBN) Valuation After Dividend Increase And New Bond Issue

Dividend increase and bond issue draw fresh attention to ABB (SWX:ABBN) ABB (SWX:ABBN) is on income investors’ radar after its board approved a higher dividend of CHF 0.94 per share at the March 19, 2026 AGM, alongside a new fixed income issuance. See our latest analysis for ABB. Those dividend and bond announcements come after a mixed few weeks for the share price, with a 1 day share price return of 1.02% but a 30 day share price decline of 6.89%, set against a 36.48% 1 year total...
SWX:BEKN
SWX:BEKNBanks

A Look At Berner Kantonalbank (SWX:BEKN) Valuation After Weaker Full Year 2025 Results

Earnings trigger puts Berner Kantonalbank in focus Berner Kantonalbank (SWX:BEKN) has drawn investor attention after publishing its full year 2025 results, which show lower net interest income and net income and indicate slightly weaker profitability compared with the previous year. See our latest analysis for Berner Kantonalbank. The earnings release comes after a strong rebound in the share price, with a 10.78% 1 month share price return and 29.04% 3 month share price return, contributing...
SWX:UBSG
SWX:UBSGCapital Markets

Assessing UBS Group (SWX:UBSG) Valuation After US National Banking Licence Approval

UBS Group (SWX:UBSG) has secured final approval for a US national banking licence, a regulatory step that allows the Swiss group to add everyday banking products alongside its existing US wealth management offerings. See our latest analysis for UBS Group. Despite the new US banking licence and a proposed cancellation of 63,776,550 repurchased shares, momentum has cooled, with a 30 day share price return of 10.34% decline and a year to date share price return of 22.95% decline, even as the 5...
SWX:COPN
SWX:COPNPharmaceuticals

Cosmo Pharmaceuticals (SWX:COPN) Valuation Check As NVIDIA GTC AI Conference Spotlight Nears

Cosmo Pharmaceuticals at NVIDIA GTC: Why This AI Conference Matters for Investors Cosmo Pharmaceuticals (SWX:COPN) is set to present at the NVIDIA GTC AI Conference on March 19 in San Jose, putting its MedTech AI capabilities and GI Genius platform in front of a focused AI audience. See our latest analysis for Cosmo Pharmaceuticals. Cosmo’s share price has had a weak short term run, with a 30 day share price return of 33.31% decline and a year to date decline of 24.57%. However, the 1 year...
SWX:IFCN
SWX:IFCNElectronic

INFICON Holding’s Valuation After Annual Earnings Reveal Stable Sales But Softer Profitability

Earnings event puts INFICON’s 2025 profitability in focus INFICON Holding (SWX:IFCN) has released full year 2025 results, reporting sales of US$673.72 million compared with US$670.95 million a year earlier. Net income was US$85.82 million, down from US$112.75 million. This shift has put profit trends under closer scrutiny for shareholders. See our latest analysis for INFICON Holding. The earnings release, which showed relatively steady sales but a lower net income, comes as INFICON’s 1 year...
SWX:MED
SWX:MEDMedical Equipment

A Look At Medartis Holding (SWX:MED) Valuation After Earnings Growth And Recent Share Price Move

Earnings event puts Medartis Holding (SWX:MED) in focus Medartis Holding (SWX:MED) is back on investors’ radar after reporting full year 2025 results, with higher sales, net income and earnings per share, followed by a special call on the same day. See our latest analysis for Medartis Holding. At a share price of CHF83.0, the stock has a 1 day share price return of 4.93% but a 30 day share price return that reflects a 12.17% decline. The 1 year total shareholder return of 9.35% suggests...
SWX:METN
SWX:METNMedical Equipment

Metall Zug (SWX:METN) Loss Of CHF 9.8 Million Tests Bullish Valuation Narratives

Metall Zug FY 2025 earnings snapshot Metall Zug (SWX:METN) has kicked off FY 2025 with first half revenue of CHF 94.2 million and a net income loss of CHF 9.8 million, setting a cautious tone around profitability. Over the recent reporting periods, revenue has shifted from CHF 181.2 million in the first half of 2024 to CHF 102.2 million in the second half and then CHF 94.2 million in the first half of 2025. Net results moved from a profit of CHF 55.6 million to a loss of CHF 3.0 million and...
SWX:CFT
SWX:CFTCapital Markets

A Look At Compagnie Financière Tradition (SWX:CFT) Valuation After Strong 2025 Results And Dividend Hike

Compagnie Financière Tradition (SWX:CFT) drew fresh attention after reporting full year 2025 results, with consolidated revenue up 11.4%, EBITDA up 24.6%, net income at CHF 134.2 million, and a proposed 11.1% dividend increase. See our latest analysis for Compagnie Financière Tradition. At a share price of CHF262.0, the stock has a 1-day share price return of 2.34%, set against a weaker 90-day share price return of an 8.39% decline. The 1-year total shareholder return of 33.52% and 5-year...
SWX:HOLN
SWX:HOLNBasic Materials

Does Holcim’s Electric Clinker Pilot With SaltX Change The Bull Case For Holcim (SWX:HOLN)?

In recent weeks, SaltX Technology announced a Joint Development Agreement with Holcim to co-develop and pilot a fully electrified, fossil-free clinker production process in Europe, targeting the world’s first fully electric cement plant by 2028 and advancing electrified calcination and sintering technologies that can be retrofitted or built into new facilities. By pairing this deep-process electrification push with Holcim’s broader moves in low‑carbon manufacturing and equipment procurement,...
SWX:GALD
SWX:GALDPharmaceuticals

A Look At Galderma Group (SWX:GALD) Valuation After Recent Share Price Weakness And Premium P/E Ratio

Galderma Group stock: recent performance snapshot Galderma Group (SWX:GALD) has drawn fresh attention after a period of mixed share performance, including a 0.3% move over the past day and a negative return over the past month and past 3 months. See our latest analysis for Galderma Group. That recent 7 day and 90 day share price weakness, with a 7 day share price return of a 1.93% decline and a 90 day share price return of a 13.16% decline from CHF142.5, contrasts with a 1 year total...
SWX:EMMN
SWX:EMMNFood

A Look At Emmi (SWX:EMMN) Valuation After FTSE All World Index Removal

Emmi dropped from FTSE All-World Index puts index-tracking flows in focus Emmi (SWX:EMMN) has been removed from the FTSE All-World Index (USD), an index change that can influence trading activity for funds tracking the benchmark and draw attention to the company’s CHF 4.36b market value. See our latest analysis for Emmi. Emmi’s latest index exit comes after a 90 day share price return of 11.8% and a year to date share price return of 14.0%, while the 1 year total shareholder return of 3.4%...
SWX:ADEN
SWX:ADENProfessional Services

A Look At Adecco Group’s (SWX:ADEN) Valuation After FTSE All World Index Removal

Index removal puts Adecco in focus for income minded investors Adecco Group (SWX:ADEN) has been removed from the FTSE All-World Index (USD), a shift that can prompt portfolio adjustments by index trackers, while its confirmed CHF 1.00 per share annual dividend keeps income considerations in view. See our latest analysis for Adecco Group. At a share price of CHF18.21, Adecco’s 30 day share price return of 15.46% and year to date share price return of 22.38%, alongside a 1 year total...
SWX:DKSH
SWX:DKSHTrade Distributors

A Look At DKSH Holding’s Valuation As It Is Removed From The FTSE All World Index

DKSH Holding (SWX:DKSH) has been removed from the FTSE All-World Index (USD), an index change that can influence trading flows as index-tracking investors and funds rebalance their portfolios. See our latest analysis for DKSH Holding. At a share price of CHF57.4, DKSH Holding has seen a 9.32% 1 month share price decline and a 19.05% 1 year total shareholder return decline, suggesting momentum has been fading even before the index removal headline. If this kind of index reshuffle has you...
SWX:IDIA
SWX:IDIABiotechs

Assessing Idorsia (SWX:IDIA) Valuation After CEO Resignation And Leadership Transition

Idorsia (SWX:IDIA) is back in focus after announcing that CEO Dr. Srishti Gupta will step down and also leave the Board of Directors. Chairman Jean Paul Clozel will take over as interim CEO. See our latest analysis for Idorsia. The leadership change comes after a mixed period for investors, with the latest CHF3.15 share price sitting against a 1 day share price return of 2.27%, a 30 day share price return of a 14.75% decline, and a very large 1 year total shareholder return of about 3x...
SWX:CFT
SWX:CFTCapital Markets

Compagnie Financière Tradition (SWX:CFT) Margin Improvement Reinforces Bullish Profitability Narrative

Compagnie Financière Tradition (SWX:CFT) has reported FY 2025 results with first half revenue of CHF 575.4 million and basic EPS of CHF 9.14, while trailing twelve month revenue came in at about CHF 1.1 billion with EPS of CHF 16.25 and earnings growth of 21.7% over the past year. Over recent periods the company has seen revenue move from CHF 533.4 million and EPS of CHF 7.98 in 1H 2024 to CHF 510.5 million and EPS of CHF 7.13 in 2H 2024, before reaching the latest 1H 2025 levels. This sets...
SWX:LLBN
SWX:LLBNBanks

A Look At Liechtensteinische Landesbank (SWX:LLBN) Valuation After Strong Demand For Its CHF 200 Million Bond Issuance

Liechtensteinische Landesbank (SWX:LLBN) has drawn investor attention after issuing a CHF 200 million senior preferred bond, a ten year fixed rate instrument that met strong demand and references the bank’s solid capital position. See our latest analysis for Liechtensteinische Landesbank. The bond issue comes as the share price trades at CHF98.8, with a 1-day share price return of 1.96% and a 90-day share price return of 18.61%. The 1-year total shareholder return of 28.92% and 5-year total...